secwatch.observer — SEC 8-K summary
======================================

Issuer:     Benitec Biopharma Inc. (BNTC)
CIK:        0001808898
Form:       8-K
Filed at:   2024-12-10T23:59:59+00:00
Accession:  0001193125-24-274395
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Benitec Biopharma authorizes 5M shares of preferred stock, effective Dec 9, 2024
--------------------------------------------------------------------------------

- Stockholders approved at Dec 4, 2024 annual meeting; amendment effective Dec 9, 2024.
- Authorizes 5,000,000 shares of preferred stock, par value $0.0001, and corresponding increase in capital stock.
- Amendment filed with Delaware Secretary of State; copy attached as Exhibit 3.1.
- No specific use of proceeds or plan for issuance disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1808898/000119312524274395/0001193125-24-274395-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1808898/000119312524274395/d919024d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-274395

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer